This finding suggests that ABCC5 plays an important role in the development of prostate cancer, especially high-risk prostate cancer and that ABCC5 can serve as a prognostic biomarker for high-risk prostate cancer and provide a new target for prostate cancer diagnosis and treatment. This evidence concerns the gene ABCC5 and prostate carcinoma.